Neuropathological Correlates of Hyperglycemia during Prolonged Polymicrobial Sepsis in Mice

Shock

Volumn 44, Issue 3, 2015, Pages 245-251

  Sonneville, Romain ^a,b,c   Derese, Inge ^a   Marques, Mirna Bastos ^a   Langouche, Lies ^a   Derde, Sarah ^a   Chatre, Laurent ^d   Chrétien, Fabrice ^c   Annane, Djillali ^b   Sharshar, Tarek ^b,c   Van Den Berghe, Greet ^a   Vanhorebeek, Ilse ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b Assistance Publique Hô Pitaux de Paris AP HP   (France)

^c Histopathologie Humaine et Modè les Animaux   (France)

^d CNRS   (France)

Author keywords

Astrocyte; GFAP glial fibrillary acidic protein; hyperglycemia; insulin; microglia; neuron; RCA 1 ricinus communis agglutinin I; RNS reactive nitrogen species; ROS reactive oxygen species; sepsis

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL DENSITY; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIPPOCAMPUS; HYPERGLYCEMIA; MALE; MICROGLIA; MOUSE; NERVE CELL LESION; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; SEPSIS; ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; FRONTAL LOBE; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANIMALS; APOPTOSIS; ASTROCYTES; BLOOD GLUCOSE; FRONTAL LOBE; HIPPOCAMPUS; HYPERGLYCEMIA; MALE; MICE, INBRED C57BL; MICROGLIA; SEPSIS;

EID: 84939491974     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000403     Document Type: Article

References (42)

1. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291 (14): 1753-1762, 2004.
2. Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK. Long-term cognitive impairment after critical illness. N Engl J Med 369 (14): 1306-1316, 2013.
3. Sonneville R, den Hertog HM, Guïza F, Gunst J, Derese I, Wouters PJ, Brouland JP, Polito A, Gray F, Chretien F. Impact of hyperglycemia on neuropathological alterations during critical illness. J Clin Endocrinol Metab 97 (6): 2113-2123, 2012.
4. Polito A, Brouland JP, Porcher R, Sonneville R, Siami S, Stevens RD, Guidoux C, Maxime V, de la Grandmaison GL, Chretien FC. Hyperglycaemia and apoptosis of microglial cells in human septic shock. Crit Care 15 (3): R131, 2011.
5. Heymann A, Sander M, Krahne D, Deja M, Weber-Carstens S, MacGuill M, Kastrup M, Wernecke KD, Nachtigall I, Spies CD. Hyperactive delirium and blood glucose control in critically ill patients. J Int Med Res 35 (5): 666-677, 2007.
6. Hopkins RO, Suchyta MR, Snow GL, Jephson A, Weaver LK, Orme JF. Blood glucose dysregulation and cognitive outcome in ARDS survivors. Brain Inj 24 (12): 1478-1484, 2010.
7. Sonneville R, den Hertog HM, Derde S, Guïza F, Derese I, Van den Berghe G, Vanhorebeek I. Increasing glucose load while maintaining normoglycemia does not evoke neuronal damage in prolonged critically ill rabbits. Clin Nutr 32 (6): 1077-1080, 2013.
8. Hermans G, Schrooten M, van Damme P, Berends N, Bouckaert B, de Vooght W, Robberecht W, Van den Berghe G. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care 13 (1): R5, 2009.
9. Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Van den Berghe G. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175 (5): 480-489, 2007.
10. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 (8): 1348-1353, 2005.
11. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55 (11): 3151-3159, 2006.
12. Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care 16 (5): R203, 2012.
13. Ooi YC, Dagi TF, Maltenfort M, Rincon F, Vibbert M, Jabbour P, Gonzalez LF, Rosenwasser R, Jallo J. Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery 71 (3): 692-702, 2012.
14. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (5): 449-461, 2006.
15. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (19): 1359-1367, 2001.
16. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 373 (9663): 547-556, 2009.
17. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 (13): 1283-1297, 2009.
18. Suh SW, Aoyama K, Chen Y, Garnier P, Matsumori Y, Gum E, Liu J, Swanson RA. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J Neurosci 23 (33): 10681-10690, 2003.
19. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 117 (4): 910-918, 2007.
20. Oddo M, Schmidt JM, Carrera E, Badjatia N, Connolly ES, Presciutti M, Ostapkovich ND, Levine JM, Le Roux P, Mayer SA. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 36 (12): 3233-3238, 2008.
21. Vespa P, Boonyaputthikul R, McArthur DL, Miller C, Etchepare M, Bergsneider M, Glenn T, Martin N, Hovda D. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med 34 (3): 850-856, 2006.
22. Vespa P, McArthur D, Miller C, O'Phelan K, Frazee J, Kidwell C, Saver J, Starkman S, Martin N. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit Care 2 (3): 274-281, 2005.
23. Vanhorebeek I, Gielen M, Boussemaere M, Wouters PJ, Grandas FG, Mesotten D, Van den Berghe G. Glucose dysregulation and neurological injury biomarkers in critically ill children. J Clin Endocrinol Metab 95 (10): 4669-4679, 2010.
24. Mesotten D, Gielen M, Sterken C, Claessens K, Hermans G, Vlasselaers D, Lemiere J, Lagae L, Gewillig M, Eyskens B. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA 308 (16): 1641-1650, 2012.
25. Marques M, Vander Perre S, Aertgeerts A, Derde S, Guïza F, Casaer MP, Hermans G, Van den Berghe G, Langouche L. Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages. Crit Care 17 (5): R193, 2013.
26. Doridot L, Chatre L, Ducat A, Vilotte JL, Lombes A, Mehats C, Barbaux S, Calicchio R, Ricchetti M, Vaiman D. Nitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a pre-eclampsia-associated gene. Antioxid Redox Signal 21 (6): 819-834, 2014.
27. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Francoise G. The neuropathology of septic shock. Brain Pathol 14 (1): 21-33, 2004.
28. Sharshar T, Gray F, Lorin de la Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, Orlikowski D, Raphael JC, Gajdos P, Annane D. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 362 (9398): 1799-1805, 2003.
29. Auer RN, Hugh J, Cosgrove E, Curry B. Neuropathologic findings in three cases of profound hypoglycemia. Clin Neuropathol 8 (2): 63-68, 1989.
30. Berg RM, Moller K, Bailey DM. Neuro-oxidative-nitrosative stress in sepsis. J Cereb Blood Flow Metab 31 (7): 1532-1544, 2011.
31. Annane D, Sharshar T. Cognitive decline after sepsis. Lancet Respir Med 3 (1): 61-69, 2015.
32. Dove A, Pollmann S, Schubert T, Wiggins CJ, von Cramon DY. Prefrontal cortex activation in task switching: an event-related fMRI study. Brain Res Cogn Brain Res 9 (1): 103-109, 2000.
33. Hernandez MT, Sauerwein HC, Jambaque I, de Guise E, Lussier F, Lortie A, Dulac O, Lassonde M. Deficits in executive functions and motor coordination in children with frontal lobe epilepsy. Neuropsychologia 40 (4): 384-400, 2002.
34. Smith AB, Taylor E, Brammer M, Rubia K. Neural correlates of switching set as measured in fast, event-related functional magnetic resonance imaging. Hum Brain Mapp 21 (4): 247-256, 2004.
35. Herzig D, Fang G, Toliver-Kinsky TE, Guo Y, Bohannon J, Sherwood ER. STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock. Shock 38 (4): 395-402, 2012.
36. Liang F, Cao J, Qin WT, Wang X, Qiu XF, Sun BW. Regulatory effect and mechanisms of carbon monoxide-releasing molecule II on hepatic energy metabolism in septic mice. World J Gastroenterol 20 (12): 3301-3311, 2014.
37. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, van Etten E, Herijgers P, Mathieu C, Van den Berghe G. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55 (4): 1096-1105, 2006.
38. Vanhorebeek I, Ellger B, de Vos R, Boussemaere M, Debaveye Y, Vander Perre S, Rabbani N, Thornalley PJ, Van den Berghe G. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit Care Med 37 (4): 1355-1364, 2009.
39. Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala EM, Louhelainen M, Foster SJ, Yaqoob MM, Thiemermann C. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit Care Med 33 (9): 1903-1912, 2005.
40. Dugo L, Collin M, Allen DA, Murch O, Foster SJ, Yaqoob MM, Thiermann C. Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition. Crit Care Med 34 (5): 1489-1496, 2006.
41. Collino M, Aragno M, Castiglia S, Tomasinelli C, Thiemermann C, Boccuzzi G, Fantozzi R. Insulin reduced cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta. Diabetes 58 (1): 235-242, 2009.
42. Semmler A, Widmann CN, Okulla T, Urbach H, Kaiser M, Widman G, Mormann F, Weide J, Fliessbach K, Hoeft A. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatry 84 (1): 62-69, 2013.